These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7651739)

  • 1. Altered specificity of IGF2 promoter imprinting during fetal development and onset of Wilms tumour.
    Taniguchi T; Schofield AE; Scarlett JL; Morison IM; Sullivan MJ; Reeve AE
    Oncogene; 1995 Aug; 11(4):751-6. PubMed ID: 7651739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relaxation of IGF2 imprinting in Wilms tumours associated with specific changes in IGF2 methylation.
    Sullivan MJ; Taniguchi T; Jhee A; Kerr N; Reeve AE
    Oncogene; 1999 Dec; 18(52):7527-34. PubMed ID: 10602511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour.
    Ogawa O; Eccles MR; Szeto J; McNoe LA; Yun K; Maw MA; Smith PJ; Reeve AE
    Nature; 1993 Apr; 362(6422):749-51. PubMed ID: 8097018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of imprinting of IGF2 sense and antisense transcripts in Wilms' tumor.
    Vu TH; Chuyen NV; Li T; Hoffman AR
    Cancer Res; 2003 Apr; 63(8):1900-5. PubMed ID: 12702581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter-specific imprinting of the human insulin-like growth factor-II gene.
    Vu TH; Hoffman AR
    Nature; 1994 Oct; 371(6499):714-7. PubMed ID: 7935819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour.
    Steenman MJ; Rainier S; Dobry CJ; Grundy P; Horon IL; Feinberg AP
    Nat Genet; 1994 Jul; 7(3):433-9. PubMed ID: 7920665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant imprinting of the insulin-like growth factor II receptor gene in Wilms' tumor.
    Xu YQ; Grundy P; Polychronakos C
    Oncogene; 1997 Mar; 14(9):1041-6. PubMed ID: 9070652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in the promoter-specific imprinting of the insulin-like growth factor-II gene in Wilms' tumor.
    Vu TH; Hoffman A
    J Biol Chem; 1996 Apr; 271(15):9014-23. PubMed ID: 8621549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constitutional relaxation of insulin-like growth factor II gene imprinting associated with Wilms' tumour and gigantism.
    Ogawa O; Becroft DM; Morison IM; Eccles MR; Skeen JE; Mauger DC; Reeve AE
    Nat Genet; 1993 Dec; 5(4):408-12. PubMed ID: 8298652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of the insulin-like growth factor-II gene in Wilms' tumor is not dependent on loss of genomic imprinting or loss of heterozygosity.
    Wang WH; Duan JX; Vu TH; Hoffman AR
    J Biol Chem; 1996 Nov; 271(44):27863-70. PubMed ID: 8910385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor II and WT1 transcript localization in human fetal kidney and Wilms' tumor.
    Yun K; Fidler AE; Eccles MR; Reeve AE
    Cancer Res; 1993 Nov; 53(21):5166-71. PubMed ID: 8221652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter-specific insulin-like growth factor 2 gene imprinting in human fetal liver and hepatoblastoma.
    Yun K; Jinno Y; Sohda T; Niikawa N; Ikeda T
    J Pathol; 1998 May; 185(1):91-8. PubMed ID: 9713365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypomethylation of the P3 promoter is associated with up-regulation of IGF2 expression in human osteosarcoma.
    Li Y; Meng G; Huang L; Guo QN
    Hum Pathol; 2009 Oct; 40(10):1441-7. PubMed ID: 19427670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter-dependent tissue-specific expressive nature of imprinting gene, insulin-like growth factor II, in human tissues.
    Wu HK; Squire JA; Song Q; Weksberg R
    Biochem Biophys Res Commun; 1997 Apr; 233(1):221-6. PubMed ID: 9144427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The human insulin-like growth factor-II promoter P1 is not restricted to liver: evidence for expression of P1 in other tissues and for a homologous promoter in baboon liver.
    Jin IH; Sinha G; Yballe C; Vu TH; Hoffman AR
    Horm Metab Res; 1995 Oct; 27(10):447-9. PubMed ID: 8575722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relaxation of imprinting of human insulin-like growth factor II gene, IGF2, in sporadic breast carcinomas.
    Wu HK; Squire JA; Catzavelos CG; Weksberg R
    Biochem Biophys Res Commun; 1997 Jun; 235(1):123-9. PubMed ID: 9196048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter-specific expression of the imprinted IGF2 gene in cattle (Bos taurus).
    Curchoe C; Zhang S; Bin Y; Zhang X; Yang L; Feng D; O'Neill M; Tian XC
    Biol Reprod; 2005 Dec; 73(6):1275-81. PubMed ID: 16120826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maintenance of genomic imprinting at the IGF2 locus in hepatoblastoma.
    Davies SM
    Cancer Res; 1993 Oct; 53(20):4781-3. PubMed ID: 8402661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developmental-dependent DNA methylation of the IGF2 and H19 promoters is correlated to the promoter activities in human liver development.
    Li X; Gray SG; Flam F; Pietsch T; Ekström TJ
    Int J Dev Biol; 1998 Jul; 42(5):687-93. PubMed ID: 9712523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromatin structure and imprinting: developmental control of DNase-I sensitivity in the mouse insulin-like growth factor 2 gene.
    Feil R; Handel MA; Allen ND; Reik W
    Dev Genet; 1995; 17(3):240-52. PubMed ID: 8565330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.